{"title":"minChemBio: Expanding Chemical Synthesis with Chemo-Enzymatic Pathways Using Minimal Transitions.","authors":"Mohit Anand, Vikas Upadhyay, Costas D Maranas","doi":"10.1021/acssynbio.4c00692","DOIUrl":null,"url":null,"abstract":"<p><p>Chemo-enzymatic pathway design aims to combine the strengths of enzymatic with chemical synthesis to traverse biomolecular design space more efficiently. While chemical reactions often struggle with regioselectivity and stereoselectivity, enzymatic conversions often encounter limitations of low enzyme activity or availability. Optimally integrating both approaches provides an opportunity to identify efficient pathways beyond the capabilities of either modality. Recently, studies have shown the advantage of leveraging enzymatic steps into industrial-scale chemical processes, such as for the blood sugar regulator Sitagliptin (Merck) and the HIV protease inhibitor Darunavir (Prozomix). Designing optimal chemo-enzymatic pathways is a complex task. It requires navigating a high-dimensional search space of potential reactions that combine individual chemical and biochemical steps while at the same time minimizing transitions between chemical catalysis and bioreactions. Here, we introduce an algorithmic approach, minChemBio, that relies on solving a mixed-integer linear programming (MILP) problem by optimally searching through known chemical and enzymatic steps extracted from the United States Patent Office (USPTO) and MetaNetX databases, respectively. minChemBio allows for the minimization of transitions between chemical and biological reactions in the pathway, thus reducing the need for costly separation and purification steps required. minChemBio was benchmarked on three case studies involving the synthesis of 2-5-furandicarboxylic acid, terephthalate, and 3-hydroxybutyrate. Identified designs included both established literature pathways as well as unexplored ones which were compared against pathways identified by existing retrosynthetic tools. minChemBio fills a current gap in the space of pathway retrosynthesis tools by controlling and minimizing the transitions between chemical catalysis and biocatalytic steps. It is accessible to users through open-source code (https://github.com/maranasgroup/chemo-enz).</p>","PeriodicalId":26,"journal":{"name":"ACS Synthetic Biology","volume":" ","pages":""},"PeriodicalIF":3.7000,"publicationDate":"2025-02-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Synthetic Biology","FirstCategoryId":"99","ListUrlMain":"https://doi.org/10.1021/acssynbio.4c00692","RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"BIOCHEMICAL RESEARCH METHODS","Score":null,"Total":0}
引用次数: 0
Abstract
Chemo-enzymatic pathway design aims to combine the strengths of enzymatic with chemical synthesis to traverse biomolecular design space more efficiently. While chemical reactions often struggle with regioselectivity and stereoselectivity, enzymatic conversions often encounter limitations of low enzyme activity or availability. Optimally integrating both approaches provides an opportunity to identify efficient pathways beyond the capabilities of either modality. Recently, studies have shown the advantage of leveraging enzymatic steps into industrial-scale chemical processes, such as for the blood sugar regulator Sitagliptin (Merck) and the HIV protease inhibitor Darunavir (Prozomix). Designing optimal chemo-enzymatic pathways is a complex task. It requires navigating a high-dimensional search space of potential reactions that combine individual chemical and biochemical steps while at the same time minimizing transitions between chemical catalysis and bioreactions. Here, we introduce an algorithmic approach, minChemBio, that relies on solving a mixed-integer linear programming (MILP) problem by optimally searching through known chemical and enzymatic steps extracted from the United States Patent Office (USPTO) and MetaNetX databases, respectively. minChemBio allows for the minimization of transitions between chemical and biological reactions in the pathway, thus reducing the need for costly separation and purification steps required. minChemBio was benchmarked on three case studies involving the synthesis of 2-5-furandicarboxylic acid, terephthalate, and 3-hydroxybutyrate. Identified designs included both established literature pathways as well as unexplored ones which were compared against pathways identified by existing retrosynthetic tools. minChemBio fills a current gap in the space of pathway retrosynthesis tools by controlling and minimizing the transitions between chemical catalysis and biocatalytic steps. It is accessible to users through open-source code (https://github.com/maranasgroup/chemo-enz).
期刊介绍:
The journal is particularly interested in studies on the design and synthesis of new genetic circuits and gene products; computational methods in the design of systems; and integrative applied approaches to understanding disease and metabolism.
Topics may include, but are not limited to:
Design and optimization of genetic systems
Genetic circuit design and their principles for their organization into programs
Computational methods to aid the design of genetic systems
Experimental methods to quantify genetic parts, circuits, and metabolic fluxes
Genetic parts libraries: their creation, analysis, and ontological representation
Protein engineering including computational design
Metabolic engineering and cellular manufacturing, including biomass conversion
Natural product access, engineering, and production
Creative and innovative applications of cellular programming
Medical applications, tissue engineering, and the programming of therapeutic cells
Minimal cell design and construction
Genomics and genome replacement strategies
Viral engineering
Automated and robotic assembly platforms for synthetic biology
DNA synthesis methodologies
Metagenomics and synthetic metagenomic analysis
Bioinformatics applied to gene discovery, chemoinformatics, and pathway construction
Gene optimization
Methods for genome-scale measurements of transcription and metabolomics
Systems biology and methods to integrate multiple data sources
in vitro and cell-free synthetic biology and molecular programming
Nucleic acid engineering.